Potassium Ion Channel Assay Service
Potassium ion channels are crucial in regulating cellular function, electrical signaling, and overall cell excitability. At Creative Biolabs, our potassium ion channel assay service provides advanced screening and analysis solutions that help researchers identify and optimize therapeutic antibodies and proteins targeting specific potassium channels.
Understanding the Role of Potassium Ion Channels in Drug Development
Potassium ion channels are integral membrane proteins found in virtually all living cells. These channels are crucial for maintaining the cell's membrane potential, regulating the electrical excitability of neurons, muscle contraction, and various cellular processes, including hormone secretion and osmoregulation. Potassium ion channels are diverse and can be categorized into several types based on their structure and activation mechanisms, including voltage-gated potassium channels, inwardly rectifying potassium channels, calcium-activated potassium channels, and two-pore domain (K2P) potassium channels. Dysfunctional potassium channels have been associated with a range of diseases, including cardiovascular disorders, neurological conditions, and certain types of cancer, making them a critical focus for drug discovery and therapeutic interventions.
Fig.1 Types of potassium channels.1
Flexible Assay Formats
Creative Biolabs provides comprehensive assay solutions for potassium channel research, utilizing both fluorescence-based and electrophysiology assays to support a wide range of applications. We have engineered cell lines that express specific potassium channels, providing a physiological context for testing the effects of clients' therapeutic candidates. This allows for a more accurate assessment of how the drugs perform in a real-world setting. These highly adaptable assays can be tailored to address specific research needs, enabling the discovery and development of potent activators, inhibitors, and modulators. Whether you are working on drug discovery, functional screening, or mechanistic studies, Creative Biolabs' assays offer the precision and flexibility needed to accelerate the development of innovative potassium channel-based therapeutics.
Various Potassium Ion Channel Targets
| Voltage-gated potassium channels | KV1.1, KV1.2, KV1.3, KV1.4, KV1.5, KV2.1, KV3.1, KV3.4, KV4.2/chip, KV4.3/chip, KV7.1(KCNQ1/KCNE), KV7.2, KV7.3, KV7.4, KV7.5, KV7.2/7.3(KCNQ2/3), KV11.1(hERG) |
|---|---|
| Inward-rectifier potassium channels | Kir2.1, Kir4.1, Kir3.1/3.4(Kach), Kir3.2(GirK2), Kir6.2/Sur2A, Kir6.2/Sur1 |
| Calcium-activated potassium channels | BKCa, IKCa, SK1, SK2, SK3 |
| Two-pore domain potassium channels | TASK-1, TASK-2, TREK-1 |
Advantages
- Comprehensive Potassium Ion Channel Profiling: We offer a detailed analysis of potassium ion channel activity in various contexts, including channel activation, inhibition, and modulation.
- Precise Data Analysis and Reporting: Creative Biolabs ensures that all data is thoroughly analyzed and presented in a clear and comprehensive format. We can also provide dose-response curves, IC50 values, and determine the potency and efficacy of your compounds.
- Wide Range of Assay Platforms: We utilize multiple assay platforms to detect and quantify potassium channel activity, including patch-clamp electrophysiology and automated fluorescence-based ion flux assays.
Why Choose Creative Biolabs?
At Creative Biolabs, we combine state-of-the-art technology with extensive expertise in ion channel research. Our team of scientists is highly experienced in the pharmacology and physiology of ion channels, providing you with accurate and reliable results. With a focus on quality, reproducibility, and customization, we offer a service that meets the unique demands of your research. In addition to our Potassium Ion Channel Assay Service, we provide a wide range of other ion channel assay services, ensuring comprehensive solutions for your drug development projects.
Reference
- Boyle, Yasmin, Terrance G. Johns, and Emily V. Fletcher. "Potassium ion channels in malignant central nervous system cancers." Cancers 14.19 (2022): 4767. Distributed under Open Access license CC BY 4.0, without modification.
Download our brochure